Abstract
Cholangiocarcinomas, malignant tumors that arise from the intrahepatic or extrahepatic bile ducts, are rare, comprising fewer than 10% of primary malignancies of the liver.1 There are only about 4000 new cases of cholangiocarcinoma per year in the United States, being diagnosed most frequently during the fifth and sixth decades of life.2 The prognosis for patients with this disease remains dismal despite advances in the operative and nonoperative management.3–7
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Anthony PP. Tumours and tumour-like lesions of the liver and biliary tract. In: MacSween RNM, Anthony PP, Scheuer PJ (eds) Pathology of the Liver, 2nd ed. Edinburgh, Churchill Livingstone, 1987, p. 574
Moto R, Kawarada Y. Diagnosis and treatment of cholangiocarcinoma and cystic adenocarcinoma of the liver. In: Okuda K, Ishak KG (eds) Neoplasms of the Liver. Tokyo, Springer, 1987, p.381
Pitt H, Dooley W, Yeo C, Cameron J. Malignancies of the biliary tract. Curr Probl Surg 32:1, 1995
Blumgart LH, Stain SC. Surgical treatment of cholangiocarcinoma. In: Sugarbaker P (ed) Hepatobiliary Cancer. Boston, Kluwer, 1994, pp.75–96
Curley SA, Levin B, Rich TA. Liver and bile ducts. In: Abeloff MD, Armitage JO, Lichter AS, Niederhuber JE (eds) Clinical Oncology. New York, Churchill Livingstone, 1995, pp. 1305–1372
Blumgart LH, Benjamin IS. Cancer of the bile ducts In: Blumgart LH (ed) Surgery of the Liver and Biliary Tract. Edinburgh, Churchill Livingstone, 1994, pp. 967–995
Vauthey J-N, Blumgart LH. Recent advances in the management of cholangiocar-cinomas. Semin Liver Dis 14:109, 1994
Nakeeb A, Pitt HA, Sohn TA, et al. Cholangiocarcinoma: a spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg 224:463, 1996
Bismuth H, Corlette MB. Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg Gynecol Obstet 140:170, 1975
Jalanko H, Kuusela P, Roberts P, et al. Comparison of a new tumor marker, CA 19–9T, with a-fetoprotein and carcinoembryonic antigen in patients with upper gastrointestinal disease. J Clin Pathol 37:218, 1984
Nichols JC, Gores GJ, LaRusso NF, et al. Diagnostic role of serum CA 19–9 for cholangiocarcinoma in patients with primary sclerosing cholangitis. Mayo Clin Proc 68:874, 1993
Ramage JK, Donaghy A, Farrant JM, et al. Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis. Gastroenterology 108:865, 1995
Liver Cancer Study Group of Japan. Primary liver cancer in Japan. Cancer 54:1747, 1984
Liver Cancer Study Group of Japan. Primary liver cancer in Japan: sixth report. Cancer 60:1400, 1987
Okuda K. Liver Cancer Study Group of Japan. Primary liver cancers in Japan. Cancer 45:2663, 1980
Liguory C, Canard JM. Tumours of the biliary system. Clin Gastroenterol 12:269, 1983
Chou FF, Sheen-Chen SM, Chen CL, et al. Prognostic factors of resectable intrahepatic cholangiocarcinoma. J Surg Oncol 59:40, 1995
Pichlmayr R, Lamesch P, Weimann A, Tusch G, Ringe B. Surgical treatment of cholangiocellular carcinoma. World J Surg 19:83, 1995
Sansalone CV, Colella G, Caccamo L, et al. Orthotopic liver transplantation for primary biliary tumors: Milan multicenter experience. Transplant Proc 26:3561, 1994
Goldstein RM, Stone M, Tillery GW, et al. Is liver transplantation indicated for cholangiocarcinoma? Am J Surg 166:768, 1993
Fardel D. Malignant neoplasms of the extrahepatic biliary ducts. Ann Surg 76:205, 1922
Altemeier WA, Gall EA, Zinninger MM, et al. Sclerosing carcinoma of the major intrahepatic bile ducts. Arch Surg 75:450, 1957
Klatskin G. Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis. Am J Med 38:241, 1965
Wheeler PG, Dawson JL, Nunnerly H, et al. Newer techniques in the diagnosis and treatment of proximal bile duct carcinoma: an analysis of 41 consecutive patients. Q J Med 50:247, 1981
Okuda K, Ohto M, Tsuchiya Y. The role of ultrasound, percutaneous transhepatic cholangiography, computed tomographic scanning, and magnetic resonance imaging in the preoperative assessment of bile duct cancer. World J Surg 12:18, 1988
Garber ST, Donald JJ, Lees WR. Cholangiocarcinoma: ultrasound features and correlation of tumor position with survival. Abdom Imaging 18:69, 1993
Neumaie, CE, Bertolotto M, Perrone R, et al. Staging of hilar cholangiocarcinoma with ultrasound. J Clin Ultrasound 23:173, 1995
Elias E, Hamlyn AN, Jain S, et al. A randomized trial of percutaneous transhepatic cholangiography with the Chiba needle versus ERCP for bile duct visualization in jaundice. Gastroenterology 71:439, 1976
Tanaka M, Ogawa Y, Matsumoto S, et al. The role of endoscopic retrograde cholangiopancreatography in preoperative assessment of bile duct cancer. World J Surg 12:27, 1988
Voyles CR, Bowley NJ, Allison DJ, et al. Carcinoma of the proximal extrahepatic biliary tree, radiologic assessment and therapeutic alternatives. Ann Surg 197:188, 1983
Blumgart LH, Baer HU. Hilar and intrahepatic biliary-euteric anastomosis. In: Blumgart LH (ed) Surgery of the Liver and Biliary Tract. Edinburgh, Churchill Livingstone, 1994
Alexandre JH, Dehni N, Bouillot JL. Stented hepaticojejunostomies after resection for cholangiocarcinoma allow access for subsequent diagnosis and therapy. Am J Surg 169:428, 1995
Mittal B, Deutsch M, Iwatsuki S. Primary cancers of the extrahepatic biliary passages. Int J Radiat Oncol Biol Phys 11:849, 1985
Mizumoto R, Kawarada Y, Suzuki H. Surgical treatment of hilar carcinoma of the bile duct. Surg Gynecol Obstet 162:153, 1986
Mizumoto R, Suzuki H. Surgical anatomy of the hepatic hilum with special reference to the caudate lobe. World J Surg 12:2, 1988
Bengmark S, Ekberg H, Evander A, et al. Major liver resection for hilar cholangiocarcinoma. Ann Surg 207:120, 1988
Iwasaki Y, Okamura T, Ozaki A, et al. Surgical treatment for carcinoma at the confluence of the major hepatic ducts. Surg Gynecol Obstet 162:457, 1986
White TT. Skeletization resection and central hepatic resection in the treatment of bile duct cancer. World J Surg 12:48, 1988
Pinson CW, Rossi RL. Extended right hepatic lobectomy, left hepatic lobectomy, and skeletonization resection for proximal bile duct cancer. World J Surg 12:52, 1988
Washburn WK, Lewis WD, Jenkins RL. Aggressive surgical resection for cholangiocarcinoma. Arch Surg 130:270, 1995
Baer HU, Stain SC, Dennison AR, Eggers B, Blumgart LH. Improvements in survival by aggressive resections of hilar cholangiocarcinoma. Ann Surg 217:20, 1993
Cameron JL, Pitt HA, Zinner MJ, et al. Management of proximal cholangiocar-cinomas by surgical resection and radiotherapy. Am J Surg 159:91, 1990
Schoenthaler R, Phillips TL, Castro J, et al. Carcinoma of the extrahepatic bile ducts: the University of California at San Francisco experience. Ann Surg 219:264, 1994
Buskirk SJ, Gunderson LL, Schild SE, et al. Analysis of failure after curative irradiation of extrahepatic bile duct carcinoma. Ann Surg 215:125, 1992
Alden ME, Mohiuddin M. The impact of radiation dose in combined external beam and intraluminal IR-192 brachytherapy for bile duct cancer. Int J Radiat Biol Phys 28:945, 1994
Tollenaar RA, vende Veld CJ, Taat CW, et al. External radiotherapy and extrahepatic bile duct cancer. Eur J Surg 157:587, 1991
Gonzalez Gonzalez D, Gerard JP, Maners AW, et al. Results of radiation therapy in carcinoma of the proximal bile duct (Klatskin tumor). Semin Liver Dis 10:131, 1990
Hayes JK, Sapozink MD, Miller FJ. Definitive radiation therapy in bile duct carcinoma. Int J Radiat Oncol Biol Phys 15:735, 1988
Pitt HA, Nakeeb A, Abrams RA, et al. Perihilar cholangiocarcinoma: postoperative radiotherapy does not improve survival. Ann Surg 221:788, 1995
McMasters KM, Tuttle TM, Leach SD, et al. Neoadjuvant chemoradiation for extrahepatic cholangiocarcinoma. Am J Surg 174:605, 1997
Evans DB, Abbruzzese JL, Cleary KR et al. Rapid-fractionation pre-operative chemoradiation for malignant periampullary neoplasms. J R Coll Surg Edinb 40:319, 1995
Oberfield RA, Rossi RL. The role of chemotherapy in the treatment of bile duct cancer. World J Surg 12:105, 1988
Curley SA, Cameron JL: Hilar bile duct cancer: a diagnostic and therapeutic challenge. Cancer Bull 44:309, 1992.
Lai ECS, Tompkins RK, Roslyn JJ, et al. Proximal bile duct cancer: quality of survival. Ann Surg 205:111, 1987
Nagorney DM, Donohue JH, Farnell MB, et al. Outcomes after curative resections of cholangiocarcinoma. Arch Surg 128:8T71, 1993
Tompkins RK, Thomas D, Wile A, et al. Prognostic factors in bile duct carcinoma. Ann Surg 194:447, 1981
Ouchi K, Suzuki M, Hashimoto L, et al. Histologic findings and prognostic factors in carcinoma of the upper bile duct. Am J Surg 157:552, 1989
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
McMasters, K.M., Curley, S.A. (1998). Treatment of Cholangiocarcinoma. In: Curley, S.A. (eds) Liver Cancer. M.D. Anderson Solid Tumor Oncology Series. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-1666-7_6
Download citation
DOI: https://doi.org/10.1007/978-1-4612-1666-7_6
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4612-7236-6
Online ISBN: 978-1-4612-1666-7
eBook Packages: Springer Book Archive